🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
This is a single centre, open-label, randomised, single dose, three-period,...
Status
Completed
Location
Simbec Research Ltd.
Start Date
2017-05-22
Trial ID
NCT03178214
Treatments Being Tested
Phase II multicenter, Canadian only study - open to 25 subjects. Study open...
Status
Unknown
Location
Hospital Maissoneuve
Start Date
2016-03
Trial ID
NCT02519816
RV568 is being developed as a possible treatment of smoking related lung di...
Status
Completed
Location
Multiple Locations
Start Date
2012-09
Trial ID
NCT01661244
RATIONALE: Monoclonal antibodies, such as bevacizumab, can block tumor grow...
Status
Unknown
Location
Memorial Sloan-Kettering Cancer Center
Start Date
2006-07
Trial ID
NCT00436709
The goal of this randomized clinical trial is to learn if topical treatment...
Status
Recruiting
Location
Genesis Cancer and Blood Institute
Start Date
2025-08-25
Trial ID
NCT06830863
This study aims to evaluate the efficacy and safety of probiotics for the p...
Status
Recruiting
Location
Breast Tumor Center, Sun Yat-sen Memorial Hospital, Sun Yat-sen University
Start Date
2025-08-07
Trial ID
NCT06892093
Treatments Being Tested
PreTerm Labor (prior to 37 weeks gestation) is the largest single cause of ...
Status
Terminated
Location
GSK Investigational Site
Start Date
2007-03
Trial ID
NCT00449709
Treatments Being Tested
Mounting preclinical and clinical evidences have proved the optimal role of...
Status
Completed
Location
Beijing Pinggu Hospital
Start Date
2021-07-08
Trial ID
NCT04403347
Treatments Being Tested
MKC-NI-002 is a Phase 1b, randomized, double-blind, placebo-controlled stud...
Status
Completed
Location
VALDI
Start Date
2025-12-22
Trial ID
NCT07344558
Treatments Being Tested
This is a Phase 1, randomized, double-blinded, placebo-controlled, single a...
Status
Completed
Location
CMAX Clinical Research Pty Ltd
Start Date
2025-03-12
Trial ID
NCT06870058
Treatments Being Tested